The German Competence Net Dementias: Standard operating procedures for the neurochemical dementia diagnostics

被引:56
作者
Lewczuk, P.
Kornhuber, J.
Wiltfang, J.
机构
[1] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Mol Neurobiol Lab, D-91054 Erlangen, Germany
[2] Ctr Clin Neuroproteom, Erlangen, Germany
关键词
dementia; body fluids; quality control; standardization;
D O I
10.1007/s00702-006-0511-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aging of population results in an increasing number of patients with dementia. Therefore, recently a BMBF-supported project, Competence Net Dementia, was launched to reveal diagnostic, therapeutic, and epidemiologic aspects of demential disorders. In this project, our task was to establish and maintain human body fluids (HBF) bank to collect cerebrospinal fluid, plasma, serum, and full blood of patients enrolled into the study. As the pre-analytical sample handling is a prerequisite of all studies aiming at finding novel disease biomarkers, standard operating procedures (SOPs) were launched by our group to allow standardized collection, storage, and shipment of the samples among all 14 University centers involved in HBF collection. Currently, to our best knowledge the CND HBF bank represents one of the largest prospectively collected set of the samples from subjects with mild cognitive impairment and early dementias. With the samples collected in the HBF bank, recently introduced analytical technologies (like e.g. surface enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS), differential gel electrophoresis (DIGE (TM)), and multiplexing) can be promptly tested with regard to their potential usefulness in neurochemical dementia diagnostics.
引用
收藏
页码:1075 / 1080
页数:6
相关论文
共 15 条
  • [1] Alzheimers Assoc, 1998, NEUROBIOL AGING, V19, P109
  • [2] Cerebrospinal fluid β-amyloid(1-42) in Alzheimer disease -: Differences between early- and late-onset Alzheimer disease and stability during the course of disease
    Andreasen, N
    Hesse, C
    Davidsson, P
    Minthon, L
    Wallin, A
    Winblad, B
    Vanderstichele, H
    Vanmechelen, E
    Blennow, K
    [J]. ARCHIVES OF NEUROLOGY, 1999, 56 (06) : 673 - 680
  • [3] Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice
    Andreasen, N
    Minthon, L
    Davidsson, P
    Vanmechelen, E
    Vanderstichele, H
    Winblad, B
    Blennow, K
    [J]. ARCHIVES OF NEUROLOGY, 2001, 58 (03) : 373 - 379
  • [4] New drugs for Alzheimer's disease and other dementias
    Bullock, R
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2002, 180 : 135 - 139
  • [5] The role of cholesterol in the biosynthesis of β-amyloid.
    Frears, ER
    Stephens, DJ
    Walters, CE
    Davies, H
    Austen, BM
    [J]. NEUROREPORT, 1999, 10 (08) : 1699 - 1705
  • [6] Determining a significant change in protein expression with DeCyder™ during a pair-wise comparison using two-dimensional difference gel electrophoresis
    Karp, NA
    Kreil, DP
    Lilley, KS
    [J]. PROTEOMICS, 2004, 4 (05) : 1421 - 1432
  • [7] Pharmacotheraphy for Alzheimer's disease.
    Knopman D.
    [J]. Current Neurology and Neuroscience Reports, 2001, 1 (5) : 428 - 434
  • [8] The amyloid-β (Aβ) peptide pattern in cerebrospinal fluid in Alzheimer's disease:: evidence of a novel carboxyterminally elongated Aβ peptide
    Lewczuk, P
    Esselmann, H
    Meyer, M
    Wollscheid, V
    Neumann, M
    Otto, M
    Maler, JM
    Rüther, E
    Kornhuber, J
    Wiltfang, J
    [J]. RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2003, 17 (12) : 1291 - 1296
  • [9] Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid β peptides
    Lewczuk, P
    Beck, G
    Esselmann, H
    Bruckmoser, R
    Zimmermann, R
    Fiszer, M
    Bibl, M
    Maler, JM
    Kornhuber, J
    Wiltfang, J
    [J]. CLINICAL CHEMISTRY, 2006, 52 (02) : 332 - 334
  • [10] Amyloid β peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry:: Evidence of novel biomarkers in Alzheimer's disease
    Lewczuk, P
    Esselmann, H
    Groemer, TW
    Bibl, M
    Maler, JM
    Steinacker, P
    Otto, M
    Kornhuber, J
    Wiltfang, J
    [J]. BIOLOGICAL PSYCHIATRY, 2004, 55 (05) : 524 - 530